These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness. Simberkoff MS Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926 [TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology Characteristics of Zhao W; Pan F; Wang B; Wang C; Sun Y; Zhang T; Shi Y; Zhang H Front Cell Infect Microbiol; 2019; 9():258. PubMed ID: 31380301 [No Abstract] [Full Text] [Related]
25. Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age. Grudzinska FS; Brodlie M; Scholefield BR; Jackson T; Scott A; Thickett DR; Sapey E Thorax; 2020 Feb; 75(2):164-171. PubMed ID: 31732687 [TBL] [Abstract][Full Text] [Related]
26. Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly? Prato R; Fortunato F; Martinelli D Curr Med Res Opin; 2016; 32(3):543-5. PubMed ID: 26652736 [TBL] [Abstract][Full Text] [Related]
27. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness. Fedson DS Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of community-acquired pneumonia in adults. Watkins RR; Lemonovich TL Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712 [TBL] [Abstract][Full Text] [Related]
29. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age. Hortal M; Estevan M; Iraola I; De Mucio B Int J Infect Dis; 2007 May; 11(3):273-7. PubMed ID: 16997592 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Mulholland K; Levine O; Nohynek H; Greenwood BM Epidemiol Rev; 1999; 21(1):43-55. PubMed ID: 10520472 [TBL] [Abstract][Full Text] [Related]
31. Community-Acquired Pneumonia in Children. Leung AKC; Wong AHC; Hon KL Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):136-144. PubMed ID: 29932038 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Michelow IC; Olsen K; Lozano J; Rollins NK; Duffy LB; Ziegler T; Kauppila J; Leinonen M; McCracken GH Pediatrics; 2004 Apr; 113(4):701-7. PubMed ID: 15060215 [TBL] [Abstract][Full Text] [Related]
36. Community acquired pneumonia. Loeb M Clin Evid; 2005 Jun; (13):1862-75. PubMed ID: 16135314 [No Abstract] [Full Text] [Related]
37. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Esposito S; Cohen R; Domingo JD; Pecurariu OF; Greenberg D; Heininger U; Knuf M; Lutsar I; Principi N; Rodrigues F; Sharland M; Spoulou V; Syrogiannopoulos GA; Usonis V; Vergison A; Schaad UB Pediatr Infect Dis J; 2012 Jun; 31(6):e78-85. PubMed ID: 22466326 [TBL] [Abstract][Full Text] [Related]
38. Etiology of childhood community acquired pneumonia and its implications for vaccination. Nascimento-Carvalho CM Braz J Infect Dis; 2001 Apr; 5(2):87-97. PubMed ID: 11493414 [TBL] [Abstract][Full Text] [Related]